Goldman Sachs Upgrades Passage Bio Inc. (PASG) to Buy
Goldman Sachs analyst Salveen Richter upgraded Passage Bio Inc. (NASDAQ: PASG) from Neutral to Buy with a price target of $30.00 (from $28.00).
Shares of Passage Bio Inc. closed at $19.96 yesterday.
You May Also Be Interested In
- UPDATE: RBC Capital Upgrades GMS Inc. (GMS) to Outperform
- Jefferies Upgrades Martin Marietta Materials (MLM) to Buy
- Dankse Bank A/S (DANSK:DC) (DNSKF) PT Raised to DKK130 at Morgan Stanley
Create E-mail Alert Related CategoriesAnalyst PT Change, Upgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!